SIPO pulls Viread patent – victory for pharma innovators?

13-08-2013

SIPO pulls Viread patent – victory for pharma innovators?

The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported.


SIPO, Gilead, Viread, Aurisco, compulsory licences

LSIPR